Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease

Hum Immunol. 2013 Oct;74(10):1363-7. doi: 10.1016/j.humimm.2013.06.036. Epub 2013 Jul 2.

Abstract

Objective: To examine the prognostic factors for visual outcome in Korean BD patients with uveitis.

Methods: Seventy-seven Korean BD patients with uveitis were enrolled. HLA-B and HLA-A genotypes were determined by PCR-based method. Visual acuity was measured by Snellen chart. Vision loss was graded into visual impairment (VI) defined as VA<20/40 for more than 6 months, loss of useful vision (LUV) as VA < 20/200, and near total blindness (NTB) as VA of light perception or worse.

Results: VI was associated with a longer duration of uveitis, posterior uveitis, and cataract, LUV with male gender, a longer duration of uveitis, posterior uveitis, and cataract, and NTB with a longer duration of uveitis, cataract, and glaucoma. HLA-B*51 and HLA-A*26:01 did not show any association with VI, LUV, or NTB. However, HLA-B*51 carriers had earlier onset of uveitis and HLA-A*26:01 was strongly associated with posterior uveitis. In patients with posterior uveitis, VI was associated with a longer duration of uveitis and cataract, LUV with a longer duration, and NTB with HLA-B*51.

Conclusion: Longer duration of uveitis, posterior uveitis, male gender, cataract, and glaucoma were found to be associated with poor visual outcome in BD-related uveitis. HLA-B*51 was associated with NTB in patients with posterior uveitis. HLA-A*26:01 showed no association with VI, LUV, or NTB, however, was strongly associated with posterior uveitis.

Keywords: BD; Behcet’s disease; CF; CI; HM; LUV; NTB; OR; PCR; S-Ag; SD; VA; VI; confidence intervals; counting fingers; hand motion; loss of useful vision; near total blindness; odds ratio; polymerase chain reaction; soluble antigen; standard deviation; visual acuity; visual impairment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Behcet Syndrome / drug therapy
  • Behcet Syndrome / etiology*
  • Behcet Syndrome / genetics
  • Female
  • HLA-A Antigens / genetics
  • HLA-B Antigens / genetics
  • HLA-B51 Antigen / genetics
  • Humans
  • Male
  • Middle Aged
  • Patient Outcome Assessment
  • Prognosis
  • Risk Factors
  • Uveitis / etiology
  • Uveitis / genetics
  • Visual Acuity*

Substances

  • HLA-A Antigens
  • HLA-A*26 antigen
  • HLA-B Antigens
  • HLA-B51 Antigen